Agreement in Risk Prediction Between the 21-Gene Recurrence...

The Oncologist 2012 / 04 Vol. 17; Iss. 4

Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier  in Early-Stage Estrogen Receptor-Positive Breast Cancer

Kelly, C. M., Bernard, P. S., Krishnamurthy, S., Wang, B., Ebbert, M. T. W., Bastien, R. R. L., Boucher, K. M., Young, E., Iwamoto, T., Pusztai, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2012-0007
Date:
April, 2012
File:
PDF, 490 KB
english, 2012
Conversion to is in progress
Conversion to is failed